Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-18,906
Closed -$2.43M 177
2023
Q2
$2.43M Sell
18,906
-159
-0.8% -$19.2K 0.4% 49
2023
Q1
$2.21M Sell
19,065
-45
-0.2% -$5.04K 0.42% 48
2022
Q4
$2.16M Sell
19,110
-123
-0.6% -$13.5K 0.45% 44
2022
Q3
$1.55M Buy
19,233
+822
+4% +$69.6K 0.31% 73
2022
Q2
$1.37M Buy
18,411
+103
+0.6% +$9.4K 0.26% 92
2022
Q1
$2.34M Buy
18,308
+456
+3% +$49.9K 0.37% 50
2021
Q4
$2.4M Buy
17,852
+140
+0.8% +$20.1K 0.35% 56
2021
Q3
$2.42M Buy
17,712
+392
+2% +$49.4K 0.37% 58
2021
Q2
$1.85M Buy
17,320
+120
+0.7% +$11.5K 0.29% 77
2021
Q1
$1.54M Buy
17,200
+736
+4% +$69.1K 0.28% 86
2020
Q4
$1.52M Buy
+16,464
New +$1.47M 0.31% 75
2020
Q3
Sell
-15,944
Closed -$1.62M 208
2020
Q2
$1.62M Buy
15,944
+11,048
+226% +$988K 0.42% 56
2020
Q1
$330K Buy
+4,896
New +$305K 0.1% 203

Other funds holding DXCM

V Wealth Advisors's DXCM Position: Q3 2023 in Review

V Wealth Advisors sold out of DexCom (DXCM) in Q3 2023, closing a stake of 18,906 shares — an estimated $2.43M sold.

V Wealth Advisors first reported a position in DXCM in Q1 2020 and held it in 13 quarters. The position peaked at $2.43M in Q2 2023. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • V Wealth Advisors reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • V Wealth Advisors sold 18,906 DexCom shares in Q3 2023, an estimated $2.43M.
  • V Wealth Advisors first reported a position in DexCom in Q1 2020 and held it in 13 quarters.
  • V Wealth Advisors's DexCom position peaked at $2.43M in Q2 2023.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on V Wealth Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.